GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $768,000 | -12.6% | 13,928 | 0.0% | 0.11% | -13.0% |
| Q2 2020 | $879,000 | +23.5% | 13,928 | 0.0% | 0.12% | +16.0% |
| Q1 2020 | $712,000 | -35.7% | 13,928 | 0.0% | 0.11% | -81.8% |
| Q4 2019 | $1,107,000 | +63.8% | 13,928 | 0.0% | 0.58% | -54.9% |
| Q3 2019 | $676,000 | -7.8% | 13,928 | 0.0% | 1.29% | -37.5% |
| Q2 2019 | $733,000 | +8.9% | 13,928 | 0.0% | 2.07% | +30.7% |
| Q1 2019 | $673,000 | +17.7% | 13,928 | 0.0% | 1.58% | +14.5% |
| Q4 2018 | $572,000 | +8.1% | 13,928 | 0.0% | 1.38% | +34.4% |
| Q3 2018 | $529,000 | -16.0% | 13,928 | 0.0% | 1.03% | -37.5% |
| Q2 2018 | $630,000 | -6.4% | 13,928 | 0.0% | 1.65% | +33.5% |
| Q1 2018 | $673,000 | +22.8% | 13,928 | 0.0% | 1.23% | +49.4% |
| Q4 2017 | $548,000 | – | 13,928 | – | 0.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
| Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
| Grace Capital | 124,749 | $6,878,000 | 5.33% |
| Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
| Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
| ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
| Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
| Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
| Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |